Buckles, VD;
Xiong, C;
Bateman, RJ;
Hassenstab, J;
Allegri, R;
Berman, SB;
Chhatwal, JP;
... Dominantly Inherited Alzheimer's Network; + view all
(2022)
Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer disease.
Alzheimer's & Dementia
, 18
(10)
pp. 1754-1764.
10.1002/alz.12505.
Preview |
Text
Fox_DIAN-NACC comparison 1-4-22 with figures.pdf - Accepted Version Download (576kB) | Preview |
Abstract
As prevention trials advance with autosomal dominant Alzheimer disease (ADAD) participants, understanding the similarities and differences between ADAD and "sporadic" late-onset AD (LOAD) is critical to determine generalizability of findings between these cohorts. Cognitive trajectories of ADAD mutation carriers (MCs) and autopsy-confirmed LOAD individuals were compared to address this question. Longitudinal rates of change on cognitive measures were compared in ADAD MCs (n = 310) and autopsy-confirmed LOAD participants (n = 163) before and after symptom onset (estimated/observed). LOAD participants declined more rapidly in the presymptomatic (preclinical) period and performed more poorly at symptom onset than ADAD participants on a cognitive composite. After symptom onset, however, the younger ADAD MCs declined more rapidly. The similar but not identical cognitive trajectories (declining but at different rates) for ADAD and LOAD suggest common AD pathologies but with some differences.
Type: | Article |
---|---|
Title: | Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer disease |
Location: | United States |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1002/alz.12505 |
Publisher version: | https://doi.org/10.1002/alz.12505 |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
Keywords: | Alzheimer disease, autosomal dominant Alzheimer disease, cognitive, comorbidities, late-onset Alzheimer disease |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases |
URI: | https://discovery.ucl.ac.uk/id/eprint/10141384 |
Archive Staff Only
View Item |